China Life Insurance Company Limited (China Life, 02628) released an inside-information announcement on 14 July 2026, forecasting a sharp increase in first-half earnings for 2026.

The insurer estimates net profit attributable to equity holders for the period 1 January–30 June 2026 at RMB128.93 billion to RMB137.12 billion, up by RMB88.00 billion to RMB96.19 billion versus the same period in 2025. This represents a year-on-year jump of approximately 215% to 235%.

In the first half of 2025, China Life reported net profit attributable to equity holders of RMB40.93 billion and profit before tax of RMB42.37 billion, equivalent to basic and diluted earnings per share of RMB1.45.

Management attributes the expected earnings surge to strengthened asset-liability interaction, expanded product and business diversification, effective liability cost control, and sustained investment performance driven by long-term, value-oriented asset allocation—particularly in new quality productive forces.

The figures are preliminary and unaudited; full details will be provided in the company’s 2026 interim report. China Life stated that no material uncertainties currently affect the accuracy of the estimate. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.